BIOTRONIK Home Monitoring® – Continuity of Care

Remote patient management with Home Monitoring offers the opportunity to deliver intelligent, event-driven care. This care is designed to improve clinical outcomes without added patient inconvenience. BIOTRONIK Home Monitoring® allows follow-up appointments to be catered to each patient, so they are seen when needed, rather than on a pre-set schedule. This helps assure that patients are monitored and healthcare providers are notified of clinically relevant device events in between in-person visits.

Studies show that Home Monitoring:

  • Provides early detection to enable early interventions—improving outcomes1,5 and reducing workload6
  • Improves patient clinical status and reduces mortality5,7
  • Can safely and efficiently reduce and replace face-to-face follow ups,1,2,3,4 easing staff workloads4
  • Helps provide optimal patient satisfaction

BIOTRONIK Home Monitoring® – Continuity of Care

  • Remote patient management with Home Monitoring offers the opportunity to deliver intelligent, event-driven care. This care is designed to improve clinical outcomes without added patient inconvenience. BIOTRONIK Home Monitoring® allows follow-up appointments to be catered to each patient, so they are seen when needed, rather than on a pre-set schedule. This helps assure that patients are monitored and healthcare providers are notified of clinically relevant device events in between in-person visits.

    Studies show that Home Monitoring:

    • Provides early detection to enable early interventions—improving outcomes1,5 and reducing workload6
    • Improves patient clinical status and reduces mortality5,7
    • Can safely and efficiently reduce and replace face-to-face follow ups,1,2,3,4 easing staff workloads4
    • Helps provide optimal patient satisfaction8

How BIOTRONIK Home Monitoring® Works:

How BIOTRONIK Home Monitoring® Works:

Unique Advantages of BIOTRONIK Home Monitoring® 

  • Automatic daily wireless data transmission and verification from day one across all devices
  • On-demand, web-based access to complete event reports, including high definition IEGMs
  • Alert-based patient care with an intelligent traffic light system for easy triage
  • Remote controlled alert settings via the web-based Home Monitoring Service Center
  • QuickCheck function. This allows for current patient data to be triggered within 3-4 min., including a full IEGM
  • Mobile transmitter with worldwide cellular connectivity at no charge to the patient
  • Easy-to-use “plug and play” patient transmitter with no patient interaction needed to complete data transmissions
  • Flexible data sharing and EHR compatible

Unique Advantages of BIOTRONIK Home Monitoring® 

  • Automatic daily wireless data transmission and verification from day one across all devices
  • On-demand, web-based access to complete event reports, including high definition IEGMs
  • Alert-based patient care with an intelligent traffic light system for easy triage
  • Remote controlled alert settings via the web-based Home Monitoring Service Center
  • QuickCheck function. This allows for current patient data to be triggered within 3-4 min., including a full IEGM
  • Mobile transmitter with worldwide cellular connectivity at no charge to the patient
  • Easy-to-use “plug and play” patient transmitter with no patient interaction needed to complete data transmissions
  • Flexible data sharing and EHR compatible

1 TRUST Study. Varma et al., Circulation (2010), 122: 325.

2 REFORM Study. Hindricks et al. European Heart Journal (2014), 98–105

3 COMPAS Study. Mabo et al., European Heart Journal (2012), 33: 1105.

4 RM-ALONE Study. García-Fernández FJ, et al. Eur Heart J. 2019 40(23):1837-1846

5 IN-TIME Study. Hindricks et al., The Lancet (2014), 384: 583-590.

6 ECOST Study. Guedon-Moreau et al., European Heart Journal (2013), 34: 605-614.

7 TRUECOIN Study. Hindricks et al., European Heart Journal 2017, 1749–1755

8 Ricci et al., Europace (2010), 12: 676.

1 TRUST Study. Varma et al., Circulation (2010), 122: 325.

2 REFORM Study. Hindricks et al. European Heart Journal (2014), 98–105

3 COMPAS Study. Mabo et al., European Heart Journal (2012), 33: 1105.

4 RM-ALONE Study. García-Fernández FJ, et al. Eur Heart J. 2019 40(23):1837-1846

5 IN-TIME Study. Hindricks et al., The Lancet (2014), 384: 583-590.

6 ECOST Study. Guedon-Moreau et al., European Heart Journal (2013), 34: 605-614.

7 TRUECOIN Study. Hindricks et al., European Heart Journal 2017, 1749–1755

8 Ricci et al., Europace (2010), 12: 676.